Re: Atryn/LEO I think that's a fair assessment. Put me in the non-belief category. On the other hand their patent moves and the blood factor deal look fine to me.
They appear to have serious competition in protein production from conventional manufacturing by big pharma and big biotech but we all know that. Perhaps this concept has its place on the very high volume needs.
Market Data 
Markets 
AI
